XG
Glycoprotein Xg
Also known as: PBDX, XG_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P55808
- Gene
- XG
- Ensembl
- ENSG00000124343
- Chromosome
- X
- Canonical length
- 180 aa
- Protein class
- Blood group antigen proteins, Predicted membrane proteins
OverviewNCBI Gene
This gene encodes the XG blood group antigen, and is located at the pseudoautosomal boundary on the short (p) arm of chromosome X. The three 5' exons reside in the pseudoautosomal region and the remaining exons within the X-specific end. A truncated copy of this gene is found on the Y chromosome at the pseudoautosomal boundary. It is transcribed, but not expected to make a Y-chromosome specific gene product. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2008]
Canonical amino-acid sequenceUniProt
180 residues, UniProt reviewed canonical sequence.
>P55808|XG
1 MESWWGLPCL AFLCFLMHAR GQRDFDLADA LDDPEPTKKP NSDIYPKPKP PYYPQPENPD
61 SGGNIYPRPK PRPQPQPGNS GNSGGYFNDV DRDDGRYPPR PRPRPPAGGG GGGYSSYGNS
121 DNTHGGDHHS TYGNPEGNMV AKIVSPIVSV VVVTLLGAAA SYFKLNNRRN CFRTHEPENVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against XG can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.66
- Highest tissue expression
- 34 nTPM
Expression across tissuesHPA
Tissue
- skin: 34 nTPM
- adipose tissue: 13 nTPM
- blood vessel: 11 nTPM
- vagina: 10 nTPM
- esophagus: 9.7 nTPM
- cervix: 9.4 nTPM
Single-cell type
- esophageal apical cells: 253 nCPM
- thymocytes: 160 nCPM
- suprabasal keratinocytes: 98 nCPM
- fibro-adipogenic progenitors: 83 nCPM
- esophageal suprabasal cells: 61 nCPM
- basal keratinocytes: 43 nCPM
Immune cell
- memory B-cell: 0.3 nTPM
- naive B-cell: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
Brain region
- white matter: 1.3 nTPM
- spinal cord: 0.8 nTPM
- medulla oblongata: 0.7 nTPM
- midbrain: 0.4 nTPM
- pons: 0.4 nTPM
- cerebellum: 0.2 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.66
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.03
- DepMap mean gene effect
- 0.08
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads XG as an antibody target. Whether an autoantibody or antibody against XG could matter depends on whether native XG is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
XG is annotated at the cell surface, where native XG is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label XG as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...